Viewing Study NCT01232595


Ignite Creation Date: 2025-12-24 @ 1:12 PM
Ignite Modification Date: 2026-01-17 @ 2:03 AM
Study NCT ID: NCT01232595
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2010-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CLFF571X2201
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators